Press releases

- ChemDiv, Torrey Pines Investment and DZNE Announce Research Collaboration

DZNE, ChemDiv, Inc. and Torrey Pines Investment jointly announced today an agreement initiating a Research and Development collaboration targeting pathways and molecular mechanisms underlying neurological health and disease.

Read more

- Researchers activate repair program for nerve fibers

Scientists of the DZNE have succeeded in releasing a molecular brake that prevents the regeneration of nerve connections. Researchers led by neurobiologist Frank Bradke report on these findings in the journal Neuron.

Read more

- Aberrant Tau Proteins Put Neuronal Networks to Sleep: Drug “Rolofylline” a Possible Antidote

The report which is based on laboratory studies suggests that the drug “Rolofylline” could possibly alleviate learning and memory problems associated with aggregating Tau proteins.

Read more

- United against Dementia among Children and Adults

Learning from each other, joint research and as such make new therapies against childhood and senile dementia more tangible – this is what the DZNE and the NCL Foundation, now want to push ahead.

Read more

- Alzheimer’s: Cellular Mechanism Provides Explanation Model for Declining Memory Performance

Loss of neuronal contacts impairs nerve cells that control activity of the hippocampus. Martin Fuhrmann and co-workers report on these findings in “Neuron”.

Read more

- Federal President Gauck visits German Center for Neurodegenerative Diseases

Today Joachim Gauck and his partner Daniela Schadt informed themself about the diverse research at DZNE.

Read more

- A New Biomarker for Nerve Cell Damage

Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Hertie Institute for Clinical Brain Research and the University of Tübingen have identified proteins in the blood and cerebrospinal fluid that reflect nerve cell damage.

Read more

- UW-Madison delegation heads to DZNE in Germany for Alzheimer's, Dementia Research

A delegation of about a dozen UW-Madison research scientists will travel to Bonn and will share insights and information on the increasingly prevalent disease.

Read more

- DZNE and Orion Corporation start strategic collaboration

DZNE and Orion Corporation have agreed to start a strategic collaboration. They want to identify novel drug targets and develop treatments for neurodegenerative disorders.

Read more

- DZNE-research impacts German legislation

Scientific results of the DZNE-led study "Dementia Networks in Germany (DemNet-D)" were considered in a new German law to strengthen health care for people with dementia. This law enables statutory and private care insurance to support regional and self-organized dementia…

Read more

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: